サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1138389

移植ボックスの世界市場-2022-2029

Global Transplant Box Market - 2022-2029
出版日: | 発行: DataM Intelligence | ページ情報: 英文 180 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
移植ボックスの世界市場-2022-2029
出版日: 2022年10月18日
発行: DataM Intelligence
ページ情報: 英文 180 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場力学

心血管疾患の有病率の高まりが、市場の成長につながります。

世界保健機関のデータによると、2021年には年間1790万人が心血管系疾患で死亡しています。疾病予防センターは、世界の死因の約32％が心血管疾患によるものであると推定しています。米国では、心臓病は人間の死因の第一位です。米国では34秒に1人が心血管系疾患で死亡しています。2020年には米国で約697,000人が心臓病で死亡しています。冠状動脈性心臓病は最も一般的な心臓病の一つで、2020年には382,820人が死亡しています。したがって、心血管疾患の症例がエスカレートすることで、心臓移植の割合が高まり、それによって移植ボックス市場の成長が促進されると予想されます。さらに、肝硬変などの慢性肝疾患の有病率の増加が、予測期間中の市場成長を押し上げると予想されます。

さらに、臓器提供を奨励する政府の取り組みがあります。臓器提供を促進するための政府の取り組みが増加していることも、予測期間中に移植ボックス市場を推進すると予想される要因のひとつです。2020年に発表された臓器提供および移植データに関する世界データベースによると、2020年には約129681個の臓器が移植されました。これらの臓器移植のうち、腎臓移植が80926件、肝臓移植が32586件、心臓移植が8101件、肺移植が5940件、膵臓移植が1970件、S・Bowel移植が158件です。

また、臓器移植プロセスの技術的進歩が臓器移植を促進し、市場の成長を後押ししています。技術的な進歩は、移植ボックス市場の成長を加速させると予想される主要な促進要因です。市場関係者は、移植前の臓器生存期間の短さなどの課題を克服するため、常に技術的に先進的なデバイスの導入に努めています。例えば、2020年3月、オランダのバイオテクノロジー企業であるMIMETASは、臓器オンチップ用のアッセイレディ製品群、OrganoPlateを発表しました。腎臓、肝臓、血管、腸、脳組織などの臓器モデルを開発するためのプラットフォームを提供します。

しかし、臓器移植には高い費用がかかるため、臓器移植を希望する患者の数は大幅に減少し、市場の成長を妨げています。さらに、臓器の需要と供給の不均衡が、臓器移植手術市場の妨げになっています。さらに、保険診療における臓器移植の不透明な償還シナリオも、予測期間中の臓器移植免疫抑制剤市場の必要性を制限しています。さらに、臓器移植の不確実な償還シナリオも、予測期間中の移植ボックス市場の状態を制限しています。

目次

第1章 調査手法と調査範囲

  • 調査手法
  • 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

  • アプリケーション別市場内訳
  • 地域別市場内訳

第4章 市場の力学

  • 市場影響要因
  • 促進要因
    • 慢性疾患の発症率の高さ
    • ヘルスケアへの支出の向上
    • 効果的な治療法の増加
  • 抑制要因
    • 臓器移植にかかる費用の高さ
  • ビジネスチャンス
  • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • バリューチェーン分析
  • PEST分析
  • プライシング分析
  • 法規制分析
  • 保険償還分析
  • アンメットニーズ
  • 特許動向

第6章 COVID-19の分析

  • COVID-19の市場分析
    • COVID-19以前の市場シナリオ
    • COVID-19の現在の市場シナリオ
    • COVID-19の後、あるいは将来のシナリオ
  • COVID-19の中での価格ダイナミクス
  • 需要-供給スペクトラム
  • パンデミック時の市場に関連する政府の取り組み
  • メーカーの戦略的な取り組み
  • まとめ

第7章 アプリケーション別

  • 心臓
  • 肝臓
  • 肺
  • 腎臓
  • その他

第8章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ地域

第9章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A（合併・買収）分析

第10章 企業プロファイル

  • HIbernicor
    • 企業概要
    • 製品ポートフォリオと説明
    • 主なハイライト
    • 財務概要
  • OrganOx Limited
  • Institut Georges Lopez-IGL
  • Organ Recovery Systems, Inc.
  • Paragonix Technologies, Inc.
  • XVIVO Perfusion AB
  • Transmedics, Inc.
  • Other Companies

第11章 DataM

目次
Product Code: DMHCIT3039

Market Overview

Transplant Box Market was valued at USD XX million in 2021. It is forecasted to reach USD XX million by 2029, growing at a CAGR of 8.2 % during the forecast period (2022-2029).

Transplant box technology is an experimental organ transplant and preservation system. It lets the donor organ continue functioning outside the body while transporting it. The transplant box keeps the heart healthy and safe by protecting it in an environment similar to conditions inside the body, which includes the delivery of warmth and nourishment by blood and oxygen. The transplant box technology improves tissue matching between recipients and donors, as the box allows more time to test the organ for potential rejection factors. The package could help grow the donor pool by allowing the donor organ to be safely transported over longer distances. Rising cases of multiple organ failure across the globe, especially in developed economies, coupled with an increasingly geriatric population, are the major factors driving the transplant box market's growth.

Market Dynamics: The growing prevalence of cardiovascular disease leads to the market's growth.

According to World Health Organization data, 17.9 million people died annually from cardiovascular disease in 2021. The Centre for disease prevention estimated that around 32% of deaths worldwide are due to cardiovascular disease. In the United States, heart disease is the leading cause of human death. One person dies every 34 seconds in the United States from cardiovascular disease. About 697,000 people in the United States died from heart disease in 2020. Coronary heart disease is one of the most common types of heart disease, killing 382,820 people in 2020. Thus, escalating cardiovascular disease cases are anticipated to raise the rate of heart transplants, thereby propelling the growth of the transplant box market. Furthermore, the increasing prevalence rate of chronic liver ailments such as liver cirrhosis is expected to boost market growth over the forecast period.

Moreover, Government initiatives to encourage organ donation. The rise in government initiatives to promote organ donation is another factor anticipated to propel the transplant box market during the forecast period. According to the global database on donation and transplantation data published in 2020, around 129681 organs were transplanted in the year 2020. Among these organ transplants, 80,926 are kidney transplants, 32,586 are liver transplants, 8,101 are heart transplants, 5,940 are lung transplants, and 1,970 are pancreas transplants and 158 S. Bowel transplants.

In addition, technological advancement in the organ transplant process drives organ transplants, thereby aiding the market's growth. Technological advancements are a major driver expected to accelerate the growth of the transplant box market. Market players always strive to introduce technologically advanced devices to overcome challenges, including the short duration of organ survival before transplantation. For instance, in March 2020, a Dutch biotech company, MIMETAS, introduced assay ready product line for organ-on-a-chip, OrganoPlate. It provides a platform for developing organ models, such as kidneys, liver, blood vessels, gut, and brain tissues.

However, the high cost associated with organ transplantations significantly reduces the number of patients opting for the design, thereby hampering the market's growth. Additionally, the disproportion in the supply and demand for organs hampering the organ transplant procedures market. Moreover, the uncertain reimbursement scenario of organ transplants in the insurance process also restricts the need for organ transplant immunosuppressant drugs market during the forecast period. Moreover, organ transplants' uncertain reimbursement scenario also limits the condition of the transplant box market during the forecast period.

Market Segmentation: Kidney segment accounted for the highest share in transplant box market.

The kidney segment is anticipated to experience a significant growth rate in the transplant box market. For instance, According to Organ Donation Statistics, in 2020, there were 80,926 kidney transplants done which was 31.70% of total transplants done globally. There 55258 kidney transplants were done from deceased donors, and 25668 kidney transplants were done from living donors. Kidney transplantation or dialysis is the only treatment option to keep a patient alive. Thus, the demand for transplant boxes is expected to surge shortly. Therefore, the need for transplant boxes in kidney transplantation is estimated to contribute interestingly to the market's growth across the globe.

Geographical Penetration: North America is the dominating region during the forecast period.

The North American market leads with the largest market share in the global transplant box market during the forecast period. A technologically advanced healthcare infrastructure drives the growth in the U.S. This, in turn, has led to a rise in the number of transplants, thereby boosting the market share in the region. Moreover, the high investment in advanced technologies in the US healthcare sector is further expected to escalate the region's market growth during the forecast period.

Furthermore, the Asia Pacific region is expected to grow at the highest CAGR globally, owing to a considerable rise in healthcare spending to establish developed healthcare infrastructure in the area. The rising geriatric population and the increase in medical tourism due to the low cost of surgical procedures contribute to the growth of the area's market. The increase in the number of chronic diseases in the area is further contributing to the development of the transplant box market in the area.

Competitive Landscape:

The transplant box market is dominated by a few companies. Some key players in the market's growth include HIbernicor, Organix Limited, Institut Georges Lopez-IGL, Organ Recovery Systems, Inc., Paragonix Technologies, Inc., XVIVO Perfusion AB, Transmedics, Inc., and TeamBest, among others. The key players execute several growth strategies, such as product launches, acquisitions, and collaborations, which are estimated to boost the transplant box market growth globally. For instance, in March 2020, Paragonix Technologies, Inc. announced that AdventHealth, a non-profit healthcare service provider in Florida, had given the nod for using its Paragonix SherpaPak CTS to preserve donors' hearts meant for transplantation. In May 2022, OrganOx, a world leader in normothermic machine perfusion (NMP), announced a partnership with Ochre Bio for chronic liver diseases. In December 2021, OrganOx announced that it got FDA approval for its metra normothermic machine perfusion (NMP) system. This device is mostly used to preserve and transport donor livers set for transplantation. The transportable device sustains donor livers in a functioning state for up to 12 hours, mimicking the environment of the human body with warm, oxygenated blood and nutrients between donation and transplantation. In August 2021, Paragonix Technologies Announced the Launch of the New OPTION On-Demand Preservation Services Network in the United States. Due to increased product demands and the need for quick service, Paragonix launched this just-in-time service to ensure the 24/7 availability of Paragonix organ preservation products.

COVID-19 Impact: Positive impact on the transplant box market.

The transplant box depends on the number of new heart diseases, lung diseases, and others. The COVID-19 pandemic has negatively impacted the growth of the market due to the decline in the number of diagnostic procedures, which has decreased the number of new cases of diseases and, ultimately, the demand for transplant boxes across the globe. Moreover, people have avoided hospital visits to contain COVID-19. Furthermore, the deviation in the development of the COVID-19 vaccine in the research institutes and pharmaceutical companies and the R&D in technologically advanced transplant boxes declined in 2020. Therefore, the transplant box market will witness a downfall in market revenue in 2020 and subsequent years.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Application
  • 3.2. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
  • 4.2. Drivers
    • 4.2.1. The high incidence rate of chronic diseases
    • 4.2.2. Improved spending on healthcare
    • 4.2.3. The rise in the availability of effective treatment methods
  • 4.3. Restraints:
    • 4.3.1. The high cost of organ transplant procedures
  • 4.4. Opportunity
  • 4.5. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Value Chain Analysis
  • 5.4. PEST Analysis
  • 5.5. Pricing Analysis
  • 5.6. Regulatory Analysis
  • 5.7. Reimbursement Analysis
  • 5.8. Unmet Needs
  • 5.9. Patent Trends

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
    • 7.1.2. Market Attractiveness Index, By Application Segment
  • 7.2. Heart
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
  • 7.3. Liver
  • 7.4. Lung
  • 7.5. Kidney
  • 7.6. Others

8. By Region

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 8.3. Market Attractiveness Index, By Region
  • 8.4. North America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.4.4.1. The U.S.
      • 8.4.4.2. Canada
      • 8.4.4.3. Mexico
  • 8.5. Europe
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.5.4.1. Germany
      • 8.5.4.2. The U.K.
      • 8.5.4.3. France
      • 8.5.4.4. Italy
      • 8.5.4.5. Spain
      • 8.5.4.6. Rest of Europe
  • 8.6. South America
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.6.4.1. Brazil
      • 8.6.4.2. Argentina
      • 8.6.4.3. Rest of South America
  • 8.7. Asia Pacific
    • 8.7.1. Introduction
    • 8.7.2. Key Region-Specific Dynamics
    • 8.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.7.4.1. China
      • 8.7.4.2. India
      • 8.7.4.3. Japan
      • 8.7.4.4. Australia
      • 8.7.4.5. Rest of Asia Pacific
  • 8.8. The Middle East and Africa
    • 8.8.1. Introduction
    • 8.8.2. Key Region-Specific Dynamics
    • 8.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

9. Competitive Landscape

  • 9.1. Competitive Scenario
  • 9.2. Market Positioning/Share Analysis
  • 9.3. Mergers and Acquisitions Analysis

10. Company Profiles

  • 10.1. HIbernicor*
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio and Description
    • 10.1.3. Key Highlights
    • 10.1.4. Financial Overview
  • 10.2. OrganOx Limited
  • 10.3. Institut Georges Lopez-IGL
  • 10.4. Organ Recovery Systems, Inc.
  • 10.5. Paragonix Technologies, Inc.
  • 10.6. XVIVO Perfusion AB
  • 10.7. Transmedics, Inc.
  • 10.8. Other Companies

11. DataM Intelligence

  • 11.1. Appendix
  • 11.2. About Us and Services
  • 11.3. Contact Us